PFG Investments LLC Acquires 2,818 Shares of Danaher Corporation $DHR

PFG Investments LLC grew its holdings in shares of Danaher Corporation (NYSE:DHR) by 45.8% in the 1st quarter, HoldingsChannel reports. The firm owned 8,974 shares of the conglomerate’s stock after acquiring an additional 2,818 shares during the quarter. PFG Investments LLC’s holdings in Danaher were worth $1,701,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. JPL Wealth Management LLC bought a new stake in Danaher in the third quarter worth about $25,000. Elevated Capital Advisors LLC purchased a new position in Danaher in the fourth quarter valued at about $26,000. WFA of San Diego LLC bought a new position in shares of Danaher during the 2nd quarter valued at approximately $26,000. Hilton Head Capital Partners LLC bought a new position in shares of Danaher during the 4th quarter valued at approximately $27,000. Finally, Clal Insurance Enterprises Holdings Ltd increased its stake in shares of Danaher by 71.6% during the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 53 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the stock. Citigroup began coverage on shares of Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price target on the stock. Rothschild & Co Redburn set a $205.00 target price on Danaher in a research report on Friday, April 17th. Evercore boosted their target price on Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research note on Tuesday, April 21st. Piper Sandler assumed coverage on Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target on the stock. Finally, TD Cowen cut their price target on Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and a consensus target price of $233.61.

Danaher Stock Performance

Shares of DHR stock opened at $197.85 on Friday. The firm’s 50 day moving average is $179.01 and its 200 day moving average is $200.54. The stock has a market capitalization of $140.03 billion, a P/E ratio of 38.27, a PEG ratio of 2.52 and a beta of 0.79. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. During the same period in the previous year, the business earned $1.88 EPS. Danaher’s revenue was up 3.7% compared to the same quarter last year. On average, sell-side analysts anticipate that Danaher Corporation will post 8.44 earnings per share for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. Danaher’s payout ratio is 30.95%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.